Crinetics Pharmaceuticals In shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crinetics Pharmaceuticals In by MPM Oncology Impact Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $25M | 557k | 44.79 |
2024-03-31 | $23M | 481k | 46.81 |
2023-09-30 | $14M | 479k | 29.74 |
2023-06-30 | $8.6M | 479k | 18.02 |
2023-03-31 | $5.8M | 360k | 16.06 |
2022-12-31 | $6.8M | 372k | 18.30 |
2022-09-30 | $7.2M | 365k | 19.64 |
2022-06-30 | $6.8M | 367k | 18.65 |
2022-03-31 | $8.0M | 367k | 21.95 |
2021-12-31 | $11M | 380k | 28.41 |
2021-09-30 | $6.3M | 298k | 21.05 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management